Ahmed A Bahrani, Erin L Abner, Charles S DeCarli, Justin M Barber, Abigail C Sutton, Pauline Maillard, Francisco Sandoval, Konstantinos Arfanakis, Yung-Chuan Yang, Arnold M Evia, Julie A Schneider, Mohamad Habes, Crystal G Franklin, Sudha Seshadri, Claudia L Satizabal, Arvind Caprihan, Jeffrey F Thompson, Gary A Rosenberg, Danny J J Wang, Kay B Jann, Chenyang Zhao, Hanzhang Lu, Paul B Rosenberg, Marilyn S Albert, Doaa G Ali, Herpreet Singh, Kristin Schwab, Steven M Greenberg, Karl G Helmer, David K Powel, Brian T Gold, Larry B Goldstein, Donna M Wilcock, Gregory A Jicha
BACKGROUND: White matter hyperintensities (WMH) that occur in the setting of vascular cognitive impairment and dementia (VCID) may be dynamic increasing or decreasing volumes or stable over time. Quantifying such changes may prove useful as a biomarker for clinical trials designed to address vascular cognitive-impairment and dementia and Alzheimer's Disease. OBJECTIVE: Conducting multi-site cross-site inter-rater and test-retest reliability of the MarkVCID white matter hyperintensity growth and regression protocol...
October 9, 2023: Journal of Alzheimer's Disease: JAD